1.1. World Health Organization 2011. Reprinted 2011. WHO Library Cataloguing-in-Publication Data Global status report on noncommunicable diseases 2010.2.2. Шальнова С., Кукушкин С., Маношкина Е., Тимофеева Т. Артериальная гипертензия и приверженность терапии. Врач. 2009; 12: 39-42.3.3. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. Update Dec 2011.4.4. Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004; 59 (7): 574-80.5.5. Sin DD, Wu L, Man SFP. The relationship between reduced lung function and cardiovascular mortality: A population-based study and a systematic review of the literature. Chest 2005; 127 (6): 1952-9.6.6. Бронхиальная астма. Руководство для врачей (формулярная система). Пульмонология. 2004; 206-41.7.7. Кароли H.A., Ребров А.П. Эндотелиальная дисфункция у больных бронхиальной астмой с хроническим легочным сердцем. Рос. мед. журн. 2002; 4: 22-4.8.8. Dogra S, Ardern C, Baker J. The relationship between age of asthma onset and cardiovascular disease in Canadians. J Asthma 2007; 44: 849-54.9.9. Perera PN, Armstrong EP, Sherrill DL, Skrepnek GH. Acute exacerbations of COPD in the United States: inpatient burden and predictors of costs and mortality. COPD 2012; 9 (2): 131-41.10.10. Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 2008; 32: 962-9.11.11. Кароли Н.А., Ребров А.П. Коморбидность у больных хронической обструктивной болезнью легких: место кардиоваскулярной патологии. Рациональная фармакотерапия в кардиологии. 2009; 4: 9-16.12.12. Anthonisen NR, Connett JE, Enright PL, Manfreda J. Lung Health Study Research Group. Hospitalizations and mortality in the Lung Health Study. Am J Respir Crit Care Med 2002; 166: 333-9.13.13. Holguin F, Folch E, Redd SC, Mannino DM. Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. Chest 2005; 128 (4): 2005-11.14.14. Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med 2002; 162 (20): 2269-76.15.15. Wang PS, Avorn J, Brookhart MA et al. Effects of noncardiovascular comorbidities on antihypertensive use in elderly hypertensives. Hypertension 2005; 46 (2): 273-9.16.16. Druss BG, Marcus SC, Olfson M, Pincus HA. The most expensive medical conditions in America. Health Aff (Millwood) 2002; 21: 105-11.17.17. Soriano JB, Visick GT, Muellerova H et al. Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. Chest 2005; 128: 2099-107.18.18. Fabbri LM, Luppi F, Beghe B, Rabe KF. Complex chronic comorbidities of COPD. Eur Respir J 2008; 31: 204-12.19.19. Диагностика и лечение артериальной гипертензии. Рекомендации Российского медицинского общества по артериальной гипертонии и Всероссийского научного общества кардиологов (4-й пересмотр). Системные гипертензии. 2010; 3: 5-26.20.20. Agusti A, Thomas A. Neff lecture. Chronic obstructive pulmonary disease: a systemic disease. Proc Am Thorac Soc 2006; 3 (6): 478-81.21.21. Fishwick D, D'Souza W, Beasley R. The asthma self-management plan system of care: what does it mean, how is it done, does it work, what models are available, what do patients want and who needs it? Patient Educ Couns 1997; 32 (Suppl. 1): S21-33.22.22. Gibson PG, Powell H. Written action plans for asthma: an evidence-based review of the key components. Thorax 2004; 59 (2): 94-9.23.23. Peeters A, Barendregt JJ, Willekens F et al. NEDCOM, the Netherlands Epidemiology and Demography Compression of Morbidity Research Group. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med 2003; 138 (1): 24-32.24.24. Di Fazio I, Franzoni S, Frisoni GB et al. Predictive role of single diseases and their combination on recovery of balance and gait in disabled elderly patients. J Am Med Dir Assoc 2006; 7 (4): 208-11.25.25. The tobacco use and dependence clinical practice guideline panel, staff, and consortium representatives. A clinical practice guideline for treating tobacco use and dependence. JAMA 2000; 28: 3244-54.26.26. Appel L, Moore T, Obarzanek E et al. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 1997; 336: 1117-24.27.27. The Australian therapeutic trial in mild hypertension: report by the Management Committee. Lancet 1980; 1: 1261-7.28.28. Labarthe Darwin and Ayala Carma - Non Drug interventions in hypertension, prevention and control. Cardiol Clin 2002; 20: 249-63.29.29. Alderman MH, Cohen HW. Dietary sodium intake and cardiovascular mortality: controversy resolved? Am J Hypertens 2012; 25 (7): 727-34.30.30. MacGregor GA, Smith SJ, Marcandu ND et al. Moderate potassium supplementation in essential hypertension. Lancet 1982; 2: 567-70.31.31. Whelton PK, He J, Cutler JA et al. Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical JAMA 1997; 277: 1624-32.32.32. Stamler J, Caggiula AW, Grandits GA. Relation of body mass and alcohol, nutrient, fibre and caffeine intakes to blood pressure in the social intervention and usual care groups in the Multiple Risk Factor Intervention Trial. Am J Clin Nutr 1997; 65 (Suppl.): S338-65.33.33. Kazaks AG, Uriu-Adams JY, Albertson TE et al. Effect of oral magnesium supplementation on measures of airway resistance and subjective assessment of asthma control and quality of life in men and women with mild to moderate asthma: a randomized placebo controlled trial. J Asthma 2010; 47 (1): 83-92.34.34. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (GOLD). Update Dec 2011.35.35. Saint-Pierre P, Bourdin A, Chanez P et al. Are overweight asthmatics more difficult to control? Allergy 2006; 61 (1): 79-84.36.36. Lavoie KL, Bacon SL, Labrecque M et al. Higher BMI is associated with worse asthma control and quality of life but not asthma severity. Respir Med 2006; 100 (4): 648-57.37.37. Dixon AE, Shade DM, Cohen RI et al. Effect of obesity on clinical presentation and response to treatment in asthma. J Asthma 2006; 43 (7): 553-8.38.38. Boulet LP, Franssen E. Influence of obesity on response to fluticasone with or without salmeterol in moderate asthma. Respir Med 2007; 101 (11): 2240-7.39.39. Aaron SD, Vandemheen KL, Boulet LP et al. Canadian Respiratory Clinical Research Consortium. Overdiagnosis of asthma in obese and nonobese adults. CMAJ 2008; 179 (11): 1121-31.40.40. Eneli IU, Skybo T, Camargo CA Jr. Weight loss and asthma: a systematic review. Thorax 2008; 63 (8): 671-6.41.41. Aaron SD, Fergusson D, Dent R et al. Effect of weight reduction on respiratory function and airway reactivity in obese women. Chest 2004; 125 (6): 2046-52.42.42. Duncan J, Hagan R, Upton J et al. The effects of an aerobic exercise program on sympathetic neural activity and blood pressure in mild hypertensive patients. Circulation 1983; 68 (4 Pt. 2): 285.43.43. Riegel G, Moreira LB, Fuchs SC et al. Long-Term Effectiveness of Non-Drug Recommendations to Treat Hypertension in a Clinical Setting. Am J Hypertens. 2012 Jul. doi: 10.1038/ajh.2012.103.44.44. Chandratilleke MG, Carson KV, Picot J. Physical training for asthma. Cochrane Database Syst Rev 2012; 5: CD001116.45.45. Behnke M, Taube C, Kirsten D et al. Home-based exercise is capable of preserving hospital-based improvements in severe chronic obstructive pulmonary disease. Respir Med 2000; 94: 1184-91.46.46. Finnerty JP, Keeping I, Bullough I et al. The effectiveness of outpatient pulmonary rehabilitation in chronic lung disease: a randomized controlled trial. Chest 2001; 119: 1705-10.47.47. Kaplan N. Non-drug treatment of hypertension. Ann Int Med 1985; 102: 359-73.48.48. Руководство по артериальной гипертонии. М.: Медиа Медика, 2006; 559-80.49.49. Stoller JK, Panos RJ, Krachman S et al. Oxygen therapy for patients with COPD: current evidence and the long-term oxygen treatment trial. Chest 2010; 138: 179-87.